{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:49:19Z","timestamp":1787312959021,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Czech Science Foundation","award":["16-07879S"],"award-info":[{"award-number":["16-07879S"]}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["15-25602A"],"award-info":[{"award-number":["15-25602A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ulla-Carin Lindquist ALS-Foundation","award":["1234"],"award-info":[{"award-number":["1234"]}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","award":["1234"],"award-info":[{"award-number":["1234"]}],"id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innlandet Hospital Trust, Norway","award":["1234"],"award-info":[{"award-number":["1234"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10534-018-0131-5","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T09:57:29Z","timestamp":1532080649000},"page":"737-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Prevention of progression in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Jan","family":"Aaseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Dusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3202-9687","authenticated-orcid":false,"given":"Per M.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"131_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00297073","volume":"48","author":"J Aaseth","year":"1981","unstructured":"Aaseth J, Alexander J, Wannag A (1981) Effect of thiocarbamate derivatives on copper, zinc, and mercury distribution in rats and mice. Arch Toxicol 48:29\u201339","journal-title":"Arch Toxicol"},{"key":"131_CR2","first-page":"203","volume":"19","author":"J Aaseth","year":"1998","unstructured":"Aaseth J, Korkina LG, Afanas\u2019ev IB (1998) Hemolytic activity of copper sulfate as influenced by epinephrine and chelating thiols. Acta Pharmacol Sin 19:203\u2013206","journal-title":"Acta Pharmacol Sin"},{"key":"131_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature20414","volume":"539","author":"A Abeliovich","year":"2016","unstructured":"Abeliovich A, Gitler AD (2016) Defects in trafficking bridge Parkinson\u2019s disease pathology and genetics. Nature 539:207\u2013216. \n                    https:\/\/doi.org\/10.1038\/nature20414","journal-title":"Nature"},{"key":"131_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/brain\/aww278","volume":"140","author":"J Acosta-Cabronero","year":"2017","unstructured":"Acosta-Cabronero J, Cardenas-Blanco A, Betts MJ, Butryn M, Valdes-Herrera JP, Galazky I, Nestor PJ (2017) The whole-brain pattern of magnetic susceptibility perturbations in Parkinson\u2019s disease. Brain 140:118\u2013131. \n                    https:\/\/doi.org\/10.1093\/brain\/aww278","journal-title":"Brain"},{"key":"131_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1212\/WNL.0b013e318225ab66","volume":"77","author":"JE Ahlskog","year":"2011","unstructured":"Ahlskog JE (2011) Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology 77:288\u2013294. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318225ab66","journal-title":"Neurology"},{"key":"131_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/ejcn.2015.92","volume":"70","author":"U Alehagen","year":"2016","unstructured":"Alehagen U, Johansson P, Bjornstedt M, Rosen A, Post C, Aaseth J (2016) Relatively high mortality risk in elderly Swedish subjects with low selenium status. Eur J Clin Nutr 70:91\u201396. \n                    https:\/\/doi.org\/10.1038\/ejcn.2015.92","journal-title":"Eur J Clin Nutr"},{"key":"131_CR7","doi-asserted-by":"publisher","first-page":"e0178614","DOI":"10.1371\/journal.pone.0178614","volume":"12","author":"U Alehagen","year":"2017","unstructured":"Alehagen U, Johansson P, Aaseth J, Alexander J, Brismar K (2017) Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens. PLoS ONE 12:e0178614. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0178614","journal-title":"PLoS ONE"},{"key":"131_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molstruc.2012.04.057","volume":"1021","author":"FA Al-Saif","year":"2012","unstructured":"Al-Saif FA, Refat MS (2012) Ten metal complexes of vitamin B 3\/niacin: Spectroscopic, thermal, antibacterial, antifungal, cytotoxicity and antitumor studies of Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Pd(II), Cd(II), Pt(IV) and Au(III) complexes. J Mol Struct 1021:40\u201352","journal-title":"J Mol Struct"},{"key":"131_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1460-9568.2008.06356.x","volume":"28","author":"DW Anderson","year":"2008","unstructured":"Anderson DW, Bradbury KA, Schneider JS (2008) Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism. Eur J Neurosci 28:610\u2013617. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06356.x","journal-title":"Eur J Neurosci"},{"key":"131_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.foodchem.2005.05.044","volume":"98","author":"M Andjelkovi\u0107","year":"2006","unstructured":"Andjelkovi\u0107 M, Van Camp J, De Meulenaer B, Depaemelaere G, Socaciu C, Verloo M, Verhe R (2006) Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food Chem 98:23\u201331","journal-title":"Food Chem"},{"key":"131_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF03033137","volume":"5","author":"M Asanuma","year":"2003","unstructured":"Asanuma M, Miyazaki I, Ogawa N (2003) Dopamine- or l-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease. Neurotox Res 5:165\u2013176","journal-title":"Neurotox Res"},{"key":"131_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2174\/1381612043453072","volume":"10","author":"M Asanuma","year":"2004","unstructured":"Asanuma M, Miyazaki I, Ogawa N (2004) Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases. Curr Pharm Des 10:695\u2013700","journal-title":"Curr Pharm Des"},{"key":"131_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol 15:1257\u20131272. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7","journal-title":"Lancet Neurol"},{"key":"131_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.mri.2015.02.021","volume":"33","author":"JH Barbosa","year":"2015","unstructured":"Barbosa JH, Santos AC, Tumas V, Liu M, Zheng W, Haacke EM, Salmon CE (2015) Quantifying brain iron deposition in patients with Parkinson\u2019s disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging 33:559\u2013565. \n                    https:\/\/doi.org\/10.1016\/j.mri.2015.02.021","journal-title":"Magn Reson Imaging"},{"key":"131_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","volume":"12","author":"KJ Barnham","year":"2008","unstructured":"Barnham KJ, Bush AI (2008) Metals in Alzheimer\u2019s and Parkinson\u2019s diseases. Curr Opin Chem Biol 12:222\u2013228. \n                    https:\/\/doi.org\/10.1016\/j.cbpa.2008.02.019","journal-title":"Curr Opin Chem Biol"},{"key":"131_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07315724.2009.10719754","volume":"28","author":"JL Barranco Quintana","year":"2009","unstructured":"Barranco Quintana JL, Allam MF, Del Castillo AS, Navajas RF (2009) Parkinson\u2019s disease and tea: a quantitative review. J Am Coll Nutr 28:1\u20136","journal-title":"J Am Coll Nutr"},{"key":"131_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fnagi.2014.00340","volume":"6","author":"GE Barreto","year":"2014","unstructured":"Barreto GE, Iarkov A, Moran VE (2014) Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson\u2019s disease. Front Aging Neurosci 6:340. \n                    https:\/\/doi.org\/10.3389\/fnagi.2014.00340","journal-title":"Front Aging Neurosci"},{"key":"131_CR18","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1468-1331.2011.03399.x","volume":"18","author":"C Becker","year":"2011","unstructured":"Becker C, Jick SS, Meier CR (2011) NSAID use and risk of Parkinson disease: a population-based case\u2013control study. Eur J Neurol 18:1336\u20131342. \n                    https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03399.x","journal-title":"Eur J Neurol"},{"key":"131_CR19","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1093\/brain\/awh666","volume":"128","author":"D Berg","year":"2005","unstructured":"Berg D et al (2005) Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson\u2019s disease. Brain 128:3000\u20133011. \n                    https:\/\/doi.org\/10.1093\/brain\/awh666","journal-title":"Brain"},{"key":"131_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington, clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"131_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neulet.2008.12.053","volume":"452","author":"J Blackinton","year":"2009","unstructured":"Blackinton J et al (2009) Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neurosci Lett 452:8\u201311. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2008.12.053","journal-title":"Neurosci Lett"},{"key":"131_CR22","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","volume":"73","author":"NI Bohnen","year":"2009","unstructured":"Bohnen NI, Muller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL (2009) History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 73:1670\u20131676. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181c1ded6","journal-title":"Neurology"},{"key":"131_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","volume":"441","author":"B Brodacki","year":"2008","unstructured":"Brodacki B, Staszewski J, Toczylowska B, Kozlowska E, Drela N, Chalimoniuk M, Stepien A (2008) Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett 441:158\u2013162. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2008.06.040","journal-title":"Neurosci Lett"},{"key":"131_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1289\/ehp.845537","volume":"55","author":"JS Bus","year":"1984","unstructured":"Bus JS, Gibson JE (1984) Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect 55:37\u201346","journal-title":"Environ Health Perspect"},{"key":"131_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H et al (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60:1059\u20131064. \n                    https:\/\/doi.org\/10.1001\/archneur.60.8.1059","journal-title":"Arch Neurol"},{"key":"131_CR26","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.freeradbiomed.2005.12.023","volume":"40","author":"SJ Chinta","year":"2006","unstructured":"Chinta SJ, Kumar JM, Zhang H, Forman HJ, Andersen JK (2006) Up-regulation of gamma-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson\u2019s disease. Free Radic Biol Med 40:1557\u20131563. \n                    https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.12.023","journal-title":"Free Radic Biol Med"},{"issue":"Suppl 1","key":"131_CR27","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","volume":"20","author":"J Costa","year":"2010","unstructured":"Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A (2010) Caffeine exposure and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studies. JAD 20(Suppl 1):S221\u2013238. \n                    https:\/\/doi.org\/10.3233\/JAD-2010-091525","journal-title":"JAD"},{"key":"131_CR28","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/aje\/kwp006","volume":"169","author":"S Costello","year":"2009","unstructured":"Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B (2009) Parkinson\u2019s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol 169:919\u2013926. \n                    https:\/\/doi.org\/10.1093\/aje\/kwp006","journal-title":"Am J Epidemiol"},{"key":"131_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"131_CR30","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","volume":"70","author":"M Deleidi","year":"2013","unstructured":"Deleidi M, Gasser T (2013) The role of inflammation in sporadic and familial Parkinson\u2019s disease. CMLS 70:4259\u20134273. \n                    https:\/\/doi.org\/10.1007\/s00018-013-1352-y","journal-title":"CMLS"},{"key":"131_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos D et al (2014) Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid Redox Signal 21:195\u2013210. \n                    https:\/\/doi.org\/10.1089\/ars.2013.5593","journal-title":"Antioxid Redox Signal"},{"key":"131_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pneurobio.2010.06.001","volume":"92","author":"KL Double","year":"2010","unstructured":"Double KL, Reyes S, Werry EL, Halliday GM (2010) Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog Neurobiol 92:316\u2013329. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2010.06.001","journal-title":"Prog Neurobiol"},{"key":"131_CR33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1039\/c2mt00174h","volume":"4","author":"C Duncan","year":"2012","unstructured":"Duncan C, White AR (2012) Copper complexes as therapeutic agents. Metallomics 4:127\u2013138. \n                    https:\/\/doi.org\/10.1039\/c2mt00174h","journal-title":"Metallomics"},{"key":"131_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jtemb.2014.05.007","volume":"31","author":"P Dusek","year":"2015","unstructured":"Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaseth J (2015) The neurotoxicity of iron, copper and manganese in Parkinson\u2019s and Wilson\u2019s diseases. J Trace Elem Med Biol 31:193\u2013203. \n                    https:\/\/doi.org\/10.1016\/j.jtemb.2014.05.007","journal-title":"J Trace Elem Med Biol"},{"key":"131_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","volume":"302","author":"N Dzamko","year":"2015","unstructured":"Dzamko N, Geczy CL, Halliday GM (2015) Inflammation is genetically implicated in Parkinson\u2019s disease. Neuroscience 302:89\u2013102. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2014.10.028","journal-title":"Neuroscience"},{"key":"131_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtemb.2009.01.004","volume":"23","author":"DG Ellingsen","year":"2009","unstructured":"Ellingsen DG, Thomassen Y, Rustad P, Molander P, Aaseth J (2009) The time-trend and the relation between smoking and circulating selenium concentrations in Norway. J Trace Elem Med Biol 23:107\u2013115. \n                    https:\/\/doi.org\/10.1016\/j.jtemb.2009.01.004","journal-title":"J Trace Elem Med Biol"},{"key":"131_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/157488606777934404","volume":"1","author":"M Etminan","year":"2006","unstructured":"Etminan M, Suissa S (2006) NSAID use and the risk of Parkinson\u2019s disease. Curr Drug Saf 1:223\u2013225","journal-title":"Curr Drug Saf"},{"key":"131_CR38","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/mds.25143","volume":"27","author":"F Fang","year":"2012","unstructured":"Fang F, Chen H, Feldman AL, Kamel F, Ye W, Wirdefeldt K (2012a) Head injury and Parkinson\u2019s disease: a population-based study. Mov Disord 27:1632\u20131635. \n                    https:\/\/doi.org\/10.1002\/mds.25143","journal-title":"Mov Disord"},{"key":"131_CR39","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/ije\/dys052","volume":"41","author":"F Fang","year":"2012","unstructured":"Fang F, Wirdefeldt K, Jacks A, Kamel F, Ye W, Chen H (2012b) CNS infections, sepsis and risk of Parkinson\u2019s disease. Int J Epidemiol 41:1042\u20131049. \n                    https:\/\/doi.org\/10.1093\/ije\/dys052","journal-title":"Int J Epidemiol"},{"key":"131_CR40","first-page":"91","volume":"2","author":"N Fatima","year":"2012","unstructured":"Fatima N (2012) Complexation, stability and stoichiometry of iron (III) with salbutamol (active ingredient of asthma drug Ventolin\u00ae). Pak J Biol Sci 2:91\u201398","journal-title":"Pak J Biol Sci"},{"key":"131_CR41","volume-title":"Metal complexes of nicotine: a group of negligible compounds","author":"AE Fazary","year":"2017","unstructured":"Fazary AE (2017) Metal complexes of nicotine: a group of negligible compounds, vol 8. Pelagia Research Library, Abha"},{"key":"131_CR42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.apmr.2008.01.013","volume":"89","author":"BE Fisher","year":"2008","unstructured":"Fisher BE et al (2008) The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson\u2019s disease. Arch Phys Med Rehabil 89:1221\u20131229. \n                    https:\/\/doi.org\/10.1016\/j.apmr.2008.01.013","journal-title":"Arch Phys Med Rehabil"},{"key":"131_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","volume":"74","author":"JJ Gagne","year":"2010","unstructured":"Gagne JJ, Power MC (2010) Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 74:995\u20131002. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181d5a4a3","journal-title":"Neurology"},{"key":"131_CR44","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","volume":"23","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Hong JS (2003) Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 23:6181\u20136187","journal-title":"J Neurosci"},{"key":"131_CR45","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1039\/c7mt00244k","volume":"9","author":"S Genoud","year":"2017","unstructured":"Genoud S et al (2017) Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson\u2019s disease brain. Metallomics 9:1447\u20131455. \n                    https:\/\/doi.org\/10.1039\/c7mt00244k","journal-title":"Metallomics"},{"key":"131_CR46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"Global Burden of Disease Cancer C","year":"2017","unstructured":"Global Burden of Disease Cancer C et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 3:524\u2013548. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2016.5688","journal-title":"JAMA Oncol"},{"key":"131_CR47","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/mds.21922","volume":"23","author":"VA Goodwin","year":"2008","unstructured":"Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (2008) The effectiveness of exercise interventions for people with Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 23:631\u2013640. \n                    https:\/\/doi.org\/10.1002\/mds.21922","journal-title":"Mov Disord"},{"key":"131_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/10715769009145692","volume":"9","author":"SA Hamburger","year":"1990","unstructured":"Hamburger SA, McCay PB (1990) Spin trapping of ibuprofen radicals: evidence that ibuprofen is a hydroxyl radical scavenger. Free Radic Res Commun 9:337\u2013342","journal-title":"Free Radic Res Commun"},{"key":"131_CR49","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/brain\/aww022","volume":"139","author":"DJ Hare","year":"2016","unstructured":"Hare DJ, Double KL (2016) Iron and dopamine: a toxic couple. Brain 139:1026\u20131035. \n                    https:\/\/doi.org\/10.1093\/brain\/aww022","journal-title":"Brain"},{"key":"131_CR50","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00213-010-1848-1","volume":"210","author":"SJ Heishman","year":"2010","unstructured":"Heishman SJ, Kleykamp BA, Singleton EG (2010) Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology 210:453\u2013469. \n                    https:\/\/doi.org\/10.1007\/s00213-010-1848-1","journal-title":"Psychopharmacology"},{"key":"131_CR51","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1212\/WNL.0000000000002102","volume":"85","author":"D Iacono","year":"2015","unstructured":"Iacono D, Geraci-Erck M, Rabin ML, Adler CH, Serrano G, Beach TG, Kurlan R (2015) Parkinson disease and incidental Lewy body disease: just a question of time? Neurology 85:1670\u20131679. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002102","journal-title":"Neurology"},{"key":"131_CR52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuropharm.2013.02.015","volume":"84","author":"AJ Jasinska","year":"2014","unstructured":"Jasinska AJ, Zorick T, Brody AL, Stein EA (2014) Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans. Neuropharmacology 84:111\u2013122. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2013.02.015","journal-title":"Neuropharmacology"},{"key":"131_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrneurol.2015.249","volume":"12","author":"LV Kalia","year":"2016","unstructured":"Kalia LV, Lang AE (2016) Parkinson disease in 2015: evolving basic, pathological and clinical concepts in PD Nature reviews. Neurology 12:65\u201366. \n                    https:\/\/doi.org\/10.1038\/nrneurol.2015.249","journal-title":"Neurology"},{"key":"131_CR54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/ane.12563","volume":"134","author":"K Kalinderi","year":"2016","unstructured":"Kalinderi K, Bostantjopoulou S, Fidani L (2016) The genetic background of Parkinson\u2019s disease: current progress and future prospects. Acta Neurol Scand 134:314\u2013326. \n                    https:\/\/doi.org\/10.1111\/ane.12563","journal-title":"Acta Neurol Scand"},{"key":"131_CR55","first-page":"274","volume":"43","author":"MC Kelton","year":"2000","unstructured":"Kelton MC, Kahn HJ, Conrath CL, Newhouse PA (2000) The effects of nicotine on Parkinson\u2019s disease. Brain Cogn 43:274\u2013282","journal-title":"Brain Cogn"},{"key":"131_CR56","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1172\/JCI114876","volume":"86","author":"TP Kennedy","year":"1990","unstructured":"Kennedy TP, Rao NV, Noah W, Michael JR, Jafri MH Jr, Gurtner GH, Hoidal JR (1990) Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron. J Clin Investig 86:1565\u20131573. \n                    https:\/\/doi.org\/10.1172\/JCI114876","journal-title":"J Clin Investig"},{"key":"131_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1523\/JNEUROSCI.20-01-00001.2000","volume":"20","author":"P Klivenyi","year":"2000","unstructured":"Klivenyi P et al (2000) Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci 20:1\u20137","journal-title":"J Neurosci"},{"key":"131_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1017\/S0317167100046333","volume":"11","author":"JW Langston","year":"1984","unstructured":"Langston JW, Ballard P (1984) Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson\u2019s disease. Can J Neurol Sci 11:160\u2013165","journal-title":"Can J Neurol Sci"},{"key":"131_CR59","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","volume":"48","author":"HH Liou","year":"1997","unstructured":"Liou HH, Tsai MC, Chen CJ, Jeng JS, Chang YC, Chen SY, Chen RC (1997) Environmental risk factors and Parkinson\u2019s disease: a case-control study in Taiwan. Neurology 48:1583\u20131588","journal-title":"Neurology"},{"key":"131_CR60","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12017-009-8108-8","volume":"11","author":"RG Lucchini","year":"2009","unstructured":"Lucchini RG, Martin CJ, Doney BC (2009) From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure. NeuroMol Med 11:311\u2013321. \n                    https:\/\/doi.org\/10.1007\/s12017-009-8108-8","journal-title":"NeuroMol Med"},{"key":"131_CR61","unstructured":"Malenka RC, Nestler EJ, Hyman SE (2009) In: Molecular neuropharmacology: a foundation for clinical neuroscience, 2nd ed. McGraw-Hill Medical, New York, p. 234"},{"key":"131_CR62","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","volume":"7","author":"A Martin-Bastida","year":"2017","unstructured":"Martin-Bastida A et al (2017) Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson\u2019s disease. Sci Rep 7:1398. \n                    https:\/\/doi.org\/10.1038\/s41598-017-01402-2","journal-title":"Sci Rep"},{"key":"131_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-130335","volume":"4","author":"MP Mattson","year":"2014","unstructured":"Mattson MP (2014) Interventions that improve body and brain bioenergetics for Parkinson\u2019s disease risk reduction and therapy. J Parkinson\u2019s Dis 4:1\u201313. \n                    https:\/\/doi.org\/10.3233\/JPD-130335","journal-title":"J Parkinson\u2019s Dis"},{"key":"131_CR64","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291","journal-title":"Neurology"},{"key":"131_CR65","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","volume":"52","author":"A Meister","year":"1983","unstructured":"Meister A, Anderson ME (1983) Glutathione. Ann Rev Biochem 52:711\u2013760. \n                    https:\/\/doi.org\/10.1146\/annurev.bi.52.070183.003431","journal-title":"Ann Rev Biochem"},{"key":"131_CR66","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S et al (2017) \u03b22-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson\u2019s disease. Science 357:891\u2013898. \n                    https:\/\/doi.org\/10.1126\/science.aaf3934","journal-title":"Science"},{"key":"131_CR67","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72:893\u2013901. \n                    https:\/\/doi.org\/10.1002\/ana.23687","journal-title":"Ann Neurol"},{"key":"131_CR68","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.neuroscience.2006.05.039","volume":"141","author":"K Ossowska","year":"2006","unstructured":"Ossowska K et al (2006) Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson\u2019s disease. Neuroscience 141:2155\u20132165. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2006.05.039","journal-title":"Neuroscience"},{"key":"131_CR69","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/BF01291884","volume":"104","author":"RK Pearce","year":"1997","unstructured":"Pearce RK, Owen A, Daniel S, Jenner P, Marsden CD (1997) Alterations in the distribution of glutathione in the substantia nigra in Parkinson\u2019s disease. J Neural Transm 104:661\u2013677. \n                    https:\/\/doi.org\/10.1007\/BF01291884","journal-title":"J Neural Transm"},{"key":"131_CR70","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1523\/JNEUROSCI.1569-07.2007","volume":"27","author":"J Peng","year":"2007","unstructured":"Peng J, Peng L, Stevenson FF, Doctrow SR, Andersen JK (2007) Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson\u2019s disease accelerate age-related neurodegeneration. J Neurosci 27:6914\u20136922. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1569-07.2007","journal-title":"J Neurosci"},{"key":"131_CR71","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","volume":"80","author":"G Pezzoli","year":"2013","unstructured":"Pezzoli G, Cereda E (2013) Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 80:2035\u20132041. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318294b3c8","journal-title":"Neurology"},{"key":"131_CR72","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. \n                    https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"131_CR73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","volume":"79","author":"RB Postuma","year":"2012","unstructured":"Postuma RB et al (2012) Caffeine for treatment of Parkinson disease: a randomized controlled trial. Neurology 79:651\u2013658. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318263570d","journal-title":"Neurology"},{"key":"131_CR74","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. \n                    https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"131_CR75","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.0000000000004568","volume":"89","author":"RB Postuma","year":"2017","unstructured":"Postuma RB et al (2017) Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): a randomized trial. Neurology 89:1795\u20131803. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004568","journal-title":"Neurology"},{"key":"131_CR76","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-008-0438-3","volume":"117","author":"JH Power","year":"2009","unstructured":"Power JH, Blumbergs PC (2009) Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol 117:63\u201373. \n                    https:\/\/doi.org\/10.1007\/s00401-008-0438-3","journal-title":"Acta Neuropathol"},{"key":"131_CR77","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/ggi.12123","volume":"14","author":"H Qi","year":"2014","unstructured":"Qi H, Li S (2014) Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson\u2019s disease. Geriatr Gerontol Int 14:430\u2013439. \n                    https:\/\/doi.org\/10.1111\/ggi.12123","journal-title":"Geriatr Gerontol Int"},{"key":"131_CR78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tox.2013.11.003","volume":"315","author":"Z Qi","year":"2014","unstructured":"Qi Z, Miller GW, Voit EO (2014) Rotenone and paraquat perturb dopamine metabolism: a computational analysis of pesticide toxicity. Toxicology 315:92\u2013101. \n                    https:\/\/doi.org\/10.1016\/j.tox.2013.11.003","journal-title":"Toxicology"},{"key":"131_CR79","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tins.2004.06.008","volume":"27","author":"M Quik","year":"2004","unstructured":"Quik M (2004) Smoking, nicotine and Parkinson\u2019s disease. Trends Neurosci 27:561\u2013568. \n                    https:\/\/doi.org\/10.1016\/j.tins.2004.06.008","journal-title":"Trends Neurosci"},{"key":"131_CR80","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainresbull.2015.02.007","volume":"113","author":"A Rahimmi","year":"2015","unstructured":"Rahimmi A, Khosrobakhsh F, Izadpanah E, Moloudi MR, Hassanzadeh K (2015) N-acetylcysteine prevents rotenone-induced Parkinson\u2019s disease in rat: an investigation into the interaction of parkin and Drp1 proteins. Brain Res Bull 113:34\u201340. \n                    https:\/\/doi.org\/10.1016\/j.brainresbull.2015.02.007","journal-title":"Brain Res Bull"},{"key":"131_CR81","volume-title":"Pharmacology","author":"HP Rang","year":"2003","unstructured":"Rang HP, Dale MM, Ritter JM, Moore PK (2003) Pharmacology. Churchill Livingstone, New York"},{"key":"131_CR82","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/rheumatology\/24.2.128","volume":"24","author":"NA Roberts","year":"1985","unstructured":"Roberts NA, Robinson PA (1985) Copper chelates of antirheumatic and anti-inflammatory agents: their superoxide dismutase-like activity and stability. Br J Rheumatol 24:128\u2013136","journal-title":"Br J Rheumatol"},{"key":"131_CR83","first-page":"1","volume":"17","author":"R Robinson","year":"2017","unstructured":"Robinson R (2017) In the pipeline-Parkinson\u2019s disease: why a common asthma drug could be a disease modifier for Parkinson\u2019s disease. Neurology 17:1\u201323","journal-title":"Neurology"},{"key":"131_CR84","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","volume":"283","author":"GW Ross","year":"2000","unstructured":"Ross GW et al (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. Jama 283:2674\u20132679","journal-title":"Jama"},{"key":"131_CR85","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1126\/science.179.4073.588","volume":"179","author":"JT Rotruck","year":"1973","unstructured":"Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588\u2013590","journal-title":"Science"},{"key":"131_CR86","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1021\/jm100380k","volume":"53","author":"S Roy","year":"2010","unstructured":"Roy S, Preston JE, Hider RC, Ma YM (2010) Glucosylated deferiprone and its brain uptake: implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood\u2013brain barrier. J Med Chem 53:5886\u20135889. \n                    https:\/\/doi.org\/10.1021\/jm100380k","journal-title":"J Med Chem"},{"key":"131_CR87","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","volume":"134","author":"RJ Smeyne","year":"2005","unstructured":"Smeyne RJ, Jackson-Lewis V (2005) The MPTP model of Parkinson\u2019s disease Brain research. Mol Brain Res 134:57\u201366. \n                    https:\/\/doi.org\/10.1016\/j.molbrainres.2004.09.017","journal-title":"Mol Brain Res"},{"key":"131_CR88","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C","volume":"55","author":"AH Stokes","year":"1999","unstructured":"Stokes AH, Hastings TG, Vrana KE (1999) Cytotoxic and genotoxic potential of dopamine. J Neurosci Res 55:659\u2013665.","journal-title":"J Neurosci Res"},{"key":"131_CR89","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","volume":"16","author":"MG Stokholm","year":"2017","unstructured":"Stokholm MG et al (2017) Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case\u2013control study. Lancet Neurol 16:789\u2013796. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(17)30173-4","journal-title":"Lancet Neurol"},{"key":"131_CR90","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1212\/WNL.39.5.660","volume":"39","author":"CM Tanner","year":"1989","unstructured":"Tanner CM et al (1989) Environmental factors and Parkinson\u2019s disease: a case-control study in China. Neurology 39:660\u2013664","journal-title":"Neurology"},{"key":"131_CR91","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM et al (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119:866\u2013872. \n                    https:\/\/doi.org\/10.1289\/ehp.1002839","journal-title":"Environ Health Perspect"},{"key":"131_CR92","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37:510\u2013518. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"key":"131_CR93","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1749-6632.2003.tb07482.x","volume":"991","author":"P Teismann","year":"2003","unstructured":"Teismann P, Vila M, Choi DK, Tieu K, Wu DC, Jackson-Lewis V, Przedborski S (2003) COX-2 and neurodegeneration in Parkinson\u2019s disease. Ann N Y Acad Sci 991:272\u2013277","journal-title":"Ann N Y Acad Sci"},{"key":"131_CR94","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1096\/fj.11-182824","volume":"25","author":"D Toulorge","year":"2011","unstructured":"Toulorge D, Guerreiro S, Hild A, Maskos U, Hirsch EC, Michel PP (2011) Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+. FASEB J 25:2563\u20132573. \n                    https:\/\/doi.org\/10.1096\/fj.11-182824","journal-title":"FASEB J"},{"key":"131_CR95","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0306-4522(96)00222-9","volume":"75","author":"G Trepanier","year":"1996","unstructured":"Trepanier G, Furling D, Puymirat J, Mirault ME (1996) Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain. Neuroscience 75:231\u2013243","journal-title":"Neuroscience"},{"key":"131_CR96","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-017-1779-6","volume":"135","author":"BG Trist","year":"2018","unstructured":"Trist BG et al (2018) Accumulation of dysfunctional SOD1 protein in Parkinson\u2019s disease is not associated with mutations in the SOD1 gene. Acta Neuropathol 135:155\u2013156. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1779-6","journal-title":"Acta Neuropathol"},{"key":"131_CR97","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3109\/00207454.2014.982795","volume":"125","author":"S Vivekanantham","year":"2015","unstructured":"Vivekanantham S, Shah S, Dewji R, Dewji A, Khatri C, Ologunde R (2015) Neuroinflammation in Parkinson\u2019s disease: role in neurodegeneration and tissue repair. Int J Neurosci 125:717\u2013725. \n                    https:\/\/doi.org\/10.3109\/00207454.2014.982795","journal-title":"Int J Neurosci"},{"key":"131_CR98","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA et al (2016) G2019S-LRRK2 expression augments alpha-synuclein sequestration into inclusions in neurons. J Neurosci 36:7415\u20137427. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3642-15.2016","journal-title":"J Neurosci"},{"key":"131_CR99","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","volume":"69","author":"AD Wahner","year":"2007","unstructured":"Wahner AD, Bronstein JM, Bordelon YM, Ritz B (2007) Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 69:1836\u20131842. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000279519.99344.ad","journal-title":"Neurology"},{"key":"131_CR100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jns.2014.10.024","volume":"347","author":"C Wakade","year":"2014","unstructured":"Wakade C, Chong R (2014) A novel treatment target for Parkinson\u2019s disease. J Neurol Sci 347:34\u201338. \n                    https:\/\/doi.org\/10.1016\/j.jns.2014.10.024","journal-title":"J Neurol Sci"},{"key":"131_CR101","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1046\/j.1471-4159.2003.02123.x","volume":"87","author":"H Wang","year":"2003","unstructured":"Wang H, Cheng E, Brooke S, Chang P, Sapolsky R (2003) Over-expression of antioxidant enzymes protects cultured hippocampal and cortical neurons from necrotic insults. J Neurochem 87:1527\u20131534","journal-title":"J Neurochem"},{"key":"131_CR102","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13:1045\u20131060. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(14)70117-6","journal-title":"Lancet Neurol"},{"key":"131_CR103","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1097\/00001756-199603220-00018","volume":"7","author":"U Wullner","year":"1996","unstructured":"Wullner U et al (1996) Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones. NeuroReport 7:921\u2013923","journal-title":"NeuroReport"},{"key":"131_CR104","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2016.02.035","volume":"322","author":"K Xu","year":"2016","unstructured":"Xu K, Di Luca DG, Orru M, Xu Y, Chen JF, Schwarzschild MA (2016) Neuroprotection by caffeine in the MPTP model of Parkinson\u2019s disease and its dependence on adenosine A2A receptors. Neuroscience 322:129\u2013137. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2016.02.035","journal-title":"Neuroscience"},{"key":"131_CR105","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/brain\/awu323","volume":"138","author":"F Yang","year":"2015","unstructured":"Yang F, Trolle Lagerros Y, Bellocco R, Adami HO, Fang F, Pedersen NL, Wirdefeldt K (2015) Physical activity and risk of Parkinson\u2019s disease in the Swedish National March Cohort. Brain 138:269\u2013275. \n                    https:\/\/doi.org\/10.1093\/brain\/awu323","journal-title":"Brain"},{"key":"131_CR106","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1046\/j.1471-4159.2003.01525.x","volume":"84","author":"J Zhang","year":"2003","unstructured":"Zhang J, Fitsanakis VA, Gu G, Jing D, Ao M, Amarnath V, Montine TJ (2003) Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J Neurochem 84:336\u2013346","journal-title":"J Neurochem"},{"key":"131_CR107","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1096\/fj.05-5214fje","volume":"20","author":"J Zhang","year":"2006","unstructured":"Zhang J et al (2006) Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis. FASEB J 20:1212\u20131214. \n                    https:\/\/doi.org\/10.1096\/fj.05-5214fje","journal-title":"FASEB J"},{"key":"131_CR108","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jchromb.2012.10.026","volume":"911","author":"L Zhang","year":"2012","unstructured":"Zhang L, Yagnik G, Jiang D, Shi S, Chang P, Zhou F (2012) Separation of intermediates of iron-catalyzed dopamine oxidation reactions using reversed-phase ion-pairing chromatography coupled in tandem with UV-visible and ESI-MS detections. J Chromatograph B Anal Technol Biomed Life Sci 911:55\u201358. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2012.10.026","journal-title":"J Chromatograph B Anal Technol Biomed Life Sci"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10534-018-0131-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-018-0131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-018-0131-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:42:11Z","timestamp":1568940131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10534-018-0131-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1007\/s10534-018-0131-5","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}